KEGG   PATHWAY: mpah05213
mpah05213                   Pathway                                

Endometrial cancer - Mus pahari (shrew mouse)
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Human Diseases; Cancer: specific types
Pathway map
mpah05213  Endometrial cancer

Mus pahari (shrew mouse) [GN:mpah]
110320006  Egf; pro-epidermal growth factor isoform X1 [KO:K04357]
110330480  Egfr; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:]
110323448  Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:]
110319750  Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:]
110327251  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:]
110328811  Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
110336420  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
110322865  Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
110312812  Pten; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:]
110337888  Pdpk1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:]
110335784  Ilk; integrin-linked protein kinase isoform X1 [KO:K06272] [EC:]
110317258  Akt2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:]
110324386  Akt1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:]
110322284  Akt3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:]
110323338  Casp9; caspase-9 isoform X1 [KO:K04399] [EC:]
110326250  Bad; bcl2-associated agonist of cell death isoform X1 [KO:K02158]
110326428  Foxo3; forkhead box protein O3 [KO:K09408]
110331195  Grb2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
110335780  Sos1; son of sevenless homolog 1 [KO:K03099]
110324314  Sos2; son of sevenless homolog 2 isoform X1 [KO:K03099]
110318967  GTPase HRas-like isoform X1 [KO:K02833]
110319567  Hras; GTPase HRas [KO:K02833]
110338480  GTPase HRas-like [KO:K02833]
110333346  GTPase HRas-like [KO:K02833]
110316221  Kras; GTPase KRas isoform X1 [KO:K07827]
110320340  Nras; GTPase NRas [KO:K07828]
110314283  Araf; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:]
110316269  Braf; serine/threonine-protein kinase B-raf [KO:K04365] [EC:]
110314893  Raf1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:]
110327244  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:]
110326321  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:]
110329343  Mapk1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:]
110320020  Mapk3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:]
110314286  Elk1; ETS domain-containing protein Elk-1 [KO:K04375]
110327431  Mlh1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
110337432  Cdh1; cadherin-1 isoform X1 [KO:K05689]
110328516  Ctnnb1; catenin beta-1 isoform X1 [KO:K02105]
110316267  Ctnna2; catenin alpha-2 isoform X1 [KO:K05691]
110333109  Ctnna1; catenin alpha-1 isoform X1 [KO:K05691]
110326998  Ctnna3; catenin alpha-3 isoform X1 [KO:K05691]
110338127  Axin1; axin-1 isoform X1 [KO:K02157]
110331423  Axin2; axin-2 [KO:K04385]
110333195  Apc; adenomatous polyposis coli protein isoform X1 [KO:K02085]
110326173  Apc2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
110329614  Gsk3b; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:]
110332085  Tcf7; transcription factor 7 isoform X1 [KO:K02620]
110315696  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
110313411  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
110319903  Lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
110334656  Myc; myc proto-oncogene protein [KO:K04377]
110322378  Ccnd1; G1/S-specific cyclin-D1 [KO:K04503]
110331731  Tp53; cellular tumor antigen p53 isoform X1 [KO:K04451]
110338236  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
110316550  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
110326839  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
110333844  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
110320030  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
110338169  Bak1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
110319597  Ddb2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
110329143  Polk; DNA polymerase kappa isoform X1 [KO:K03511] [EC:]
110331339  Erbb2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:]
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Ryan AJ, Susil B, Jobling TW, Oehler MK.
Endometrial cancer.
Cell Tissue Res 322:53-61 (2005)
Lax SF.
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
Virchows Arch 444:213-23 (2004)
Shiozawa T, Konishi I.
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
Int J Clin Oncol 11:13-21 (2006)
Hecht JL, Mutter GL.
Molecular and pathologic aspects of endometrial carcinogenesis.
J Clin Oncol 24:4783-91 (2006)
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
Molecular pathology of endometrial hyperplasia and carcinoma.
Hum Pathol 32:569-77 (2001)
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
J Clin Oncol 22:3126-32 (2004)
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
Cancer Res 55:5693-8 (1995)
Kim D, Chung J.
Akt: versatile mediator of cell survival and beyond.
J Biochem Mol Biol 35:106-15 (2002)
mpah04010  MAPK signaling pathway
mpah04012  ErbB signaling pathway
mpah04060  Cytokine-cytokine receptor interaction
mpah04110  Cell cycle
mpah04115  p53 signaling pathway
mpah04151  PI3K-Akt signaling pathway
mpah04310  Wnt signaling pathway
mpah04520  Adherens junction
KO pathway

DBGET integrated database retrieval system